CRC
Clinical trials for CRC explained in plain language.
Never miss a new study
Get alerted when new CRC trials appear
Sign up with your email to follow new studies for CRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug called JAB-21822 in 29 adults with advanced solid tumors (like lung or colon cancer) that have a specific KRAS G12C mutation. The goal was to see if the drug is safe and can shrink tumors. Participants took the drug by mouth, alone or with another dru…
Matched conditions: CRC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New drug combo shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis early-phase study tested a combination of two drugs, cabozantinib and TAS-102, in 15 people with metastatic colorectal cancer that had stopped responding to standard treatments. The main goal was to find the safest dose and check for side effects. The study is complete and h…
Matched conditions: CRC
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New pill targets hard-to-treat cancers with BRAF mutation
Disease control CompletedThis early-stage study tested a new drug called CFT1946 in 89 adults with advanced solid tumors that have a specific BRAF V600 gene change. The goal was to find safe doses and see if the drug, given alone or with other medicines, can shrink tumors. The study focused on safety and…
Matched conditions: CRC
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Biopsy clues may predict cancer spread
Knowledge-focused CompletedThis study examined tumor samples from 150 people with colorectal cancer to see if a specific feature called 'intratumoral budding' could predict whether the cancer had spread to lymph nodes or other organs. Researchers used a special stain to count these buds and then compared t…
Matched conditions: CRC
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated May 17, 2026 01:59 UTC